NHS England has confirmed, in its primary care bulletin, that community pharmacy contractors are not required to submit their completed New Medicine Service (NMS) quarterly summary data to the NHS Business Services Authority for July to September 2022 (Quarter 2), as this requirement has been postponed again.

PSNC is pressing NHS England for a review of this data requirement and for early confirmation for contractors on a decision regarding reporting for quarters 3 and 4 in 2022/23.

As soon as there is further information on the future of this reporting requirement, PSNC will communicate this to contractors via the usual channels.

The post NMS: Continued pause to NMS quarterly data reporting appeared first on PSNC Website.